Acusphere, Inc. announced today the issuance of U.S. Patent No. 7,160,557 B2, entitled "Matrices Formed of Polymer and Hydrophobic Compounds for Use in Drug Delivery." The patent covers the sustained drug release features of Acusphere's porous microparticle formulations using a biodegradable shell material. These porous microparticle formulations have tightly controlled size distributions, and can allow drugs to be released over periods of tim...Tuesday, 16-Jan-2007 / [ Details... ]
CogState has announced that it has been issued a patent from the Unites States Patent & Trade Mark Office (US patent no. 7,163,513) for the key technology platform used in its computer-based tests of brain function. The patent term adjustment is 229 days.As announced in July 2006, this patent broadly protects CogState's psychological testing method which randomises the nature and timing of the visual stimuli presented to a subject as well a...Tuesday, 16-Jan-2007 / [ Details... ]
Ryogen LLC announced today that the company have entered into a nonexclusive license agreement with Invitrogen Corporation, whereby Invitrogen has licensed from Ryogen the patent directed to the clinically important Aminopeptidase P gene. The US Patent No. 6,399,349 titled "Human Aminopeptidase P Gene," which is the subject of the License Agreement, covers the XPNPEP2 gene sequenced by Dr. James Ryan, Chief Scientist of Ryogen LLC. XPNPEP2 codes...Tuesday, 9-Jan-2007 / [ Details... ]
MedImmune issued the following statement regarding today's U.S. Supreme Court decision in MedImmune, Inc. vs. Genentech, Inc. et al.: By granting MedImmune's appeal, the U.S. Supreme Court has brought further clarity to the patent litigation process -- specifically, the use of declaratory judgments by licensees of questionable patents.The Court's decision means MedImmune is free to pursue its complaint regarding non-infringe...Tuesday, 9-Jan-2007 / [ Details... ]
Applied Digital Solutions, though its subsidiary VeriChip Corporation has announced today that the U.S. Patent and Trademark Office has granted VeriChip Corp. a patent for its portable RFID asset location system. The patent, No. # 7,116,230, combines RFID tagging technology with a portable receiver to track the location of assets within a fixed setting, such as a building or warehouse. Rather than relying on a network of fixed receiv...Monday, 8-Jan-2007 / [ Details... ]
NanoMed Pharmaceuticals has announced that founders Russell J. Mumper, Ph.D. and Michael Jay, Ph.D. have been issued U.S. Patent 7,153,525 entitled "Microemulsions As Precursors To Solid Nanoparticles." Their invention, assigned to the University of Kentucky Research Foundation and licensed exclusively to NanoMed Pharmaceuticals, covers processes and applications of Nanotemplate Engineering, a nanoparticle manufacturing technology used to f...Wednesday, 3-Jan-2007 / [ Details... ]
Cytogen Corporation has announced that it has been issued United States patent number 7,135,457 covering its oral drug delivery agents - random peptide compositions that bind to gastro-intestinal tract (GIT) transport receptors. The patent specifically covers compositions of Cytogen's oral delivery agents that are capable of facilitating transport of an active agent through a human or animal gastro-intestinal tract (GIT), and derivatives and ana...Tuesday, 28-Nov-2006 / [ Details... ]
VNUS Medical Technologies, Inc has announced that United States District Judge Maxine M. Chesney of the United States District Court for the Northern District of California issued a Markman order in the litigation brought by VNUS Medical Technologies against Diomed Holdings, Inc. and Diomed, Inc., AngioDynamics, Inc. and Vascular Solutions, Inc. (the "defendants"). VNUS Medical Technologies has filed patent litigation against the defendants, alleg...Thursday, 23-Nov-2006 / [ Details... ]
Human DNA patents are unlikely to be the barrier to medical and scientific innovation that they were first feared to be, according to new findings published this week. In fact in recent years new guidelines at patent offices, legal developments, commercial sentiment and the growing volume of genetic information in the public domain have together raised the bar on patentability of genes and other genetic material.In particular, rigorous examination and prohibitive costs are discouraging sp...Thursday, 8-Feb-2007 / [ Details... ]
Martinsried-based drug discovery and development company 4SC AG announced today that the US Patent and Trademark Office (ASPTO) has granted the patent with the US patent number 7,176,241 for its drug candidate SC12267. This patent protects the DHODH inhibitor that is used by 4SC to treat rheumatoid arthritis and is currently undergoing testing in clinical phase IIa. In addition, the patent also covers further back-up substances related to SC12267, m...Tuesday, 6-Feb-2007 / [ Details... ]